Found: 21
Select item for more details and to access through your institution.
Impact of Tamoxifen on Vorinostat-Induced Human Immunodeficiency Virus Expression in Women on Antiretroviral Therapy: AIDS Clinical Trials Group A5366, The MOXIE Trial.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 8, p. 1389, doi. 10.1093/cid/ciac136
- By:
- Publication type:
- Article
Time to Viral Rebound After Interruption of Modern Antiretroviral Therapies.
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 5, p. 865, doi. 10.1093/cid/ciab541
- By:
- Publication type:
- Article
Statistical Challenges When Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical Trials.
- Published in:
- Journal of Infectious Diseases, 2023, v. 288, p. S101, doi. 10.1093/infdis/jiad285
- By:
- Publication type:
- Article
Immune Status and SARS-CoV-2 Viral Dynamics.
- Published in:
- Journal of Infectious Diseases, 2023, v. 288, p. S111, doi. 10.1093/infdis/jiad200
- By:
- Publication type:
- Article
A phase I/II randomized, placebo-controlled trial of romidepsin in persons with HIV-1 on suppressive antiretroviral therapy to assess safety and activation of HIV-1 expression (A5315).
- Published in:
- 2021
- By:
- Publication type:
- journal article
Lopinavir/Ritonavir Monotherapy as Second-line Antiretroviral Treatment in Resource-Limited Settings: Week 104 Analysis of AIDS Clinical Trials Group (ACTG) A5230.
- Published in:
- Clinical Infectious Diseases, 2015, v. 60, n. 10, p. 1552, doi. 10.1093/cid/civ109
- By:
- Publication type:
- Article
HIV-1 DNA Decay Dynamics in Blood During More Than a Decade of Suppressive Antiretroviral Therapy.
- Published in:
- Clinical Infectious Diseases, 2014, v. 59, n. 9, p. 1312, doi. 10.1093/cid/ciu585
- By:
- Publication type:
- Article
Drug Susceptibility and Resistance Mutations After First-Line Failure in Resource Limited Settings.
- Published in:
- Clinical Infectious Diseases, 2014, v. 59, n. 5, p. 706
- By:
- Publication type:
- Article
Predictors of SARS-CoV-2 RNA From Nasopharyngeal Swabs and Concordance With Other Compartments in Nonhospitalized Adults With Mild to Moderate COVID-19.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 11, p. 1, doi. 10.1093/ofid/ofac618
- By:
- Publication type:
- Article
Continuing or adding IL-2 in patients treated withantiretroviral therapy (ACTG Protocol A5051, arollover trial of ACTG Protocol A328).
- Published in:
- AIDS Research & Therapy, 2010, v. 7, p. 30, doi. 10.1186/1742-6405-7-30
- By:
- Publication type:
- Article
HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers.
- Published in:
- 2018
- By:
- Publication type:
- journal article
IMMUNE STATUS AND SARS-CoV-2 VIRAL DYNAMICS.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 287
- By:
- Publication type:
- Article
TIXAGEVIMAB/CILGAVIMAB IM AND IV FOR COVID-19: A RANDOMIZED CONTROLLED ACTIV-2 TRIAL.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 225
- By:
- Publication type:
- Article
No Evidence for Decay of the Latent Reservoir in HIV-1-Infected Patients Receiving Intensive Enfuvirtide-Containing Antiretroviral Therapy.
- Published in:
- Journal of Infectious Diseases, 2010, v. 201, n. 2, p. 293, doi. 10.1086/649569
- By:
- Publication type:
- Article
A Randomized, Partially Blinded Phase 2 Trial of Antiretroviral Therapy, HIV-Specific Immunizations, and Interleukin-2 Cycles to Promote Efficient Control of Viral Replication (ACTG A5024).
- Published in:
- Journal of Infectious Diseases, 2006, v. 194, n. 12, p. 1672
- By:
- Publication type:
- Article
Safety and Efficacy of Combined Tixagevimab and Cilgavimab Administered Intramuscularly or Intravenously in Nonhospitalized Patients With COVID-19: 2 Randomized Clinical Trials.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 4, p. e2310039, doi. 10.1001/jamanetworkopen.2023.10039
- By:
- Publication type:
- Article
The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Continued Slow Decay of the Residual Plasma Viremia Level in HIV-1-Infected Adults Receiving Long-term Antiretroviral Therapy.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Antiretroviral drug resistance in HIV-1-infected patients experiencing persistent low-level viremia during first-line therapy.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Antiretroviral Drug Resistance in HIV-1�� "Infected Patients Experiencing Persistent Low-Level Viremia During First-Line Therapy.
- Published in:
- 2011
- By:
- Publication type:
- Abstract